Alexandria Real Estate Equities is a REIT that pioneered the life science real estate niche, specializing in the development and operation of collaborative Megacampus ecosystems designed for innovative life science companies and research institutions. The company is the preeminent owner, operator, and developer of Class A properties in leading life science innovation clusters such as Greater Boston, San Francisco Bay Area, San Diego, and Seattle, serving a diverse tenant base including multinational pharmaceutical companies, biotechnology firms, medical device companies, research institutions, and government agencies. Alexandria generates revenue through rental income from its North American portfolio of life science properties and provides strategic capital to transformative life science companies through its venture capital platform, leveraging its unique property clustering model to enhance tenant recruitment and retention while driving long-term asset value.